Features
Update on Idiopathic Macular Telangiectasia Type 2
Research is elucidating pathology and therapies.
By Emily Y. Chew, MD, Martin Friedlander, MD, PhD
Helping Patients Maximize Low-Vision Technology on Smart Devices
Retina specialists are part of the solution.
By Dorrie Rush
Techniques and Outcomes for Phacovitrectomy
Exploring combined vs sequential surgery.
By Victor M. Villegas, MD, Timothy G. Murray, MD, MBA, FACS
Implementation of Telemedicine in a Retina Practice
The benefit to patients is worth the effort.
By MURTAZA ADAM, MD
Web Exclusives
Extended Ophthalmoscopy and Audit Preparedness for Retinal Physicians
Be aware of vulnerabilities.
By Jenny Edgar, CPC, CPCO, OCS, OCSR, JOY WOODKE, COE, OCS
Departments
Anti-VEGF Therapy in Macular Edema Due to Retinal Vein Occlusion
Real-world outcomes differ from those of clinical trials.
By Thomas A. Ciulla, MD, MBA
UPFRONT: Practice Patterns in Combined Cataract–Retina Surgery
By Peter K. Kaiser, MD
CLINICAL TRIAL DOWNLOAD: Data on OpRegen for Geographic Atrophy
Retina specialists discuss encouraging early results.
By Yasha Modi, MD
CONTROVERSIES IN CARE: Shaving the Vitreous Base in Vitrectomy for RRD
What makes for the perfect shave?
By Michael Colucciello, MD, Justis P. Ehlers, MD
CODING Q&A: When Exams and Minor Procedures Share a Date
The distinction is different for minor procedures than for a major surgery.
By Suzanne L. Corcoran, COE
NEW PRODUCT APPLICATIONS: A New Standard for Retinal Imaging
TrueColor images offer a host of benefits.
By Karen Appold, contributing writer
News
Opthea Cleared for 2 Phase 3 Trials in Wet AMD
Pan-VEGF therapy would complement Eylea and Lucentis.
By Jerry Helzner, contributing editor
Combination Ranibizumab-PDT Superior in EVEREST II Study
By Jerry Helzner, contributing editor